Kim Wedervang

Phase III randomized clinical trial comparing the efficacy of neoadjuvant chemotherapy and standard treatment in patients with locally advanced colon cancer: The NeoCol trial.

Lars Henrik Jensen, Monica L Kjaer, Finn Ole Larsen et al. · Journal of Clinical Oncology · 2023 · 46 citations

Medicine, Oncology, Surgery +17

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy

Mette Thune Mouritzen, Andreas Carus, Morten Ladekarl et al. · Cancers · 2021 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

Nicholas C. Turner, Cristina Saura, Philippe Aftimos et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

Mette Thune Mouritzen, Karen F. Junker, Andreas Carus et al. · Acta Oncologica · 2022 · 19 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy

Birgitte Bjørnhart, Charlotte Kristiansen, Jon Thor Asmussen et al. · Thrombosis Research · 2022 · 15 citations

Medicine, Immunology, Oncology +16